Work

Real-world use of accelerated approval oncology drugs subsequently withdrawn in the United States.

Year: 2025

Type: conference-abstract

Study design: Observational Study

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.16_suppl.e13573

Authors: Francesca Coutinho, Aliza R Karpes-Matusevich, Vincent Miller

Language: English

Topic: Pharmaceutical Economics and Policy

Subfield: Economics and Econometrics

Field: Economics, Econometrics and Finance

Domain: Social Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4410808889

Cites:

Cited by:

Related to: 10